Prognostic tools are essential in assessing disease severity and survival rates in advanced liver disease, guiding clinical decisions and treatment planning. These tools help assess suitability of patients of chronic liver disease (CLD) for undertaking advanced procedures as trans-jugular intrahepatic portosystemic shunt (TIPS). Nurses, as vital members of the care team, play a critical role in assisting in delivery of patient care. This review highlights key prognostic tools used in hepatology, their scoring, interpretations, and significance. The three common prognostic tools used in hepatology are: Child Pugh Turcotte (CTP) score, Model for End-Stage Liver Disease (MELD), and Albumin-Bilirubin (ALBI). On comparing the effectiveness there have been mixed results. All three have been used depending on the symptomatology, need of the patient, number of complications and extent of liver damage. The prognostic tools remain as the guide for planning and delivering quality care to the CLD patients.